Physician profile
Stephen G Weinstein
NPI 1366556102
$1,588.77
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $756 · 2020: $74.69 · 2021: $224 · 2022: $221 · 2023: $296 · 2024: $17.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.75 |
| Education | $117.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $633.74 | 2019-2021 | |
| Astellas Pharma US INC | $253.51 | 2023 | Veozah, Myrbetriq |
| Becton, Dickinson and Company | $200.77 | 2021-2022 | |
| Therapeuticsmd, INC. | $126.87 | 2019-2022 | |
| Focal Therapeutics, INC. | $92.15 | 2019 | |
| Medtronic USA, INC. | $79.00 | 2019 | |
| Pfizer INC. | $63.10 | 2019-2024 | |
| Covidien LP | $37.80 | 2019 | |
| Exact Sciences Corporation | $23.83 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $20.28 | 2022 | |
| Hologic Sales and Service, LLC | $16.47 | 2019 | |
| Avion Pharmaceuticals | $14.78 | 2019 | |
| Aspira Women'S Health INC | $14.15 | 2022 | |
| Coopersurgical, INC. | $12.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.